Market by Device Type, Route of Administration, End-user, and Country | Forecast 2019-2028
According to Triton, the injectable drug delivery market in Latin America is expected to proliferate with a CAGR of 9.34% in the forecast period of 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries evaluated in this market are:
• Brazil
• Mexico
• Rest of latin america
Latin America's injectable drug delivery market is majorly driven by the rise in the prevalence of chronic diseases and the enhanced pharmaceutical consumption owing to the adoption of drug delivery systems and technologies in the region. The increasing number of cases of cancer, diabetes, asthma, CVDs, etc., For instance, ProMexico, which is the Mexican federal government's trust fund, states that, owing to the increase in pharmaceutical consumption in the country in 2016-2017, the industry has shown revenue growth of $2,336 million. The body further states that, pharmaceutical consumption in the period between 2015 and 2020 will grow stupendously, registering 26,856 by 2020. These factors are favoring the injectable drug delivery market growth in the Latin American region.
Brazil's population has grown multifold in the past few decades. With the increase in life expectancy, there is a large number of older adults in the country. Individuals belonging to this population group are highly susceptible to various diseases. This has raised the demand for injectable drug delivery systems in the country, owing to the convenience of use provided by them. Further, according to an article, 600,000 new cases of cancer were reported in the country in 2018-2019. Injectable drug delivery technology is known to play a vital role in the treatment of cancer, and hence, the growing prevalence of cancer has enhanced the demand for these systems. All these factors are channeling the Brazilian injectable drug delivery market's growth.
Founded in 1970, Elcam Medical develops and manufactures disposable medical devices for the OEM market. Elcam Drug Delivery Devices is one of its four major business verticals. The company offers a wide range of drug delivery systems, including FlexiQ mMU and FlexiQ eMUP, thus contributing significantly to the global market. There are several opportunities for the organization to manufacture drug-injecting devices for severe central nervous system disorders.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANT
2.2.2. THREAT OF SUBSTITUTE
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. INTENSITY OF COMPETITIVE RIVALRY
2.3. KEY INSIGHT
2.4. KEY BUYING CRITERIA
2.5. MARKET ATTRACTIVENESS INDEX
2.6. MARKET DRIVERS
2.6.1. INCREASING GERIATRIC POPULATION
2.6.2. TECHNOLOGICAL ADVANCEMENT
2.6.3. GROWING OCCURRENCE OF AUTOIMMUNE DISEASES
2.7. MARKET RESTRAINT
2.7.1. HIGH MANUFACTURING COST OF INJECTABLE DRUG DELIVERY SYSTEMS
2.8. MARKET OPPORTUNITY
2.8.1. DEVELOPMENT OF BETTER INJECTABLE SYSTEMS
2.8.2. INCREASE IN HEALTHCARE EXPENDITURE
2.9. MARKET CHALLENGES
2.9.1. DEVELOPMENTS IN ALTERNATE DRUG DELIVERY SYSTEMS
2.9.2. STRINGENT REGULATIONS
3. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY DEVICE TYPE
3.1. PEN INJECTOR
3.2. AUTO-INJECTOR
3.3. NEEDLE-FREE INJECTOR
3.4. PREFILLED SYRINGE
4. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
4.1. SUBCUTANEOUS
4.2. INTRAMUSCULAR
4.3. INTRAVENOUS (IV)
4.4. OTHER ROUTE OF ADMINISTRATION
5. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY END-USER
5.1. CLINICS/ PHYSICIAN OFFICES
5.2. AMBULATORY CARE
5.3. HOSPITAL
5.4. HOME-BASED
5.5. OTHER END-USERS
6. INJECTABLE DRUG DELIVERY MARKET – LATIN AMERICA
6.1. COUNTRY ANALYSIS
6.1.1. BRAZIL
6.1.2. MEXICO
6.1.3. REST OF LATIN AMERICA
7. COMPANY PROFILES
7.1. BAXTER INTERNATIONAL INC
7.2. BECTON DICKINSON AND COMPANY (BD)
7.3. ELCAM MEDICAL
7.4. ELI LILLY AND COMPANY
7.5. GERRESHEIMER
7.6. INJEX
7.7. NOVARTIS AG
7.8. NOVO NORDISK A/S
7.9. PFIZER INC
7.10. SANOFI SA
7.11. SCHOTT AG
7.12. TERUMO CORPORATION
7.13. TEVA PHARMACEUTICALS
7.14. WEST PHARMACEUTICALS
7.15. YPSOMED HOLDING AG
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS
TABLE 1 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY REGION, 2019-2028 ($ MILLION)
TABLE 2 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2028 ($ MILLION)
TABLE 3 DIFFERENT TYPES OF INSULIN PEN INJECTORS
TABLE 4 MARKETED NEEDLE-FREE INJECTORS PRODUCTS
TABLE 5 LYOPHILIZED DRUGS WHICH ARE USED IN PREFILLED SYRINGE
TABLE 6 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)
TABLE 7 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)
TABLE 8 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
FIGURE 1 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)
FIGURE 2 KEY BUYING IMPACT ANALYSIS
FIGURE 3 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2028 ($ MILLION)
FIGURE 4 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY AUTO-INJECTOR, 2019-2028 ($ MILLION)
FIGURE 5 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2028 ($ MILLION)
FIGURE 6 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2028 ($ MILLION)
FIGURE 7 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2028 ($ MILLION)
FIGURE 8 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2028 ($ MILLION)
FIGURE 9 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2028 ($ MILLION)
FIGURE 10 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)
FIGURE 11 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/PHYSICIAN OFFICES, 2019-2028 ($ MILLION)
FIGURE 12 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2028 ($ MILLION)
FIGURE 13 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2028 ($ MILLION)
FIGURE 14 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY HOME-BASED, 2019-2028 ($ MILLION)
FIGURE 15 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2028 ($ MILLION)
FIGURE 16 BRAZIL INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)
FIGURE 17 MEXICO INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)
FIGURE 18 REST OF LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)